Product
MK-2060
5 clinical trials
6 indications
Indication
End-Stage Renal DiseaseIndication
End-Stage Kidney DiseaseIndication
Kidney FailureIndication
ChronicIndication
Chronic Kidney FailureIndication
DialysisClinical trial
A Single-dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-2060 in Japanese Older Participants With End-stage Renal Disease on Dialysis.Status: Completed, Estimated PCD: 2024-02-15
Clinical trial
A Single-and Multiple Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Subcutaneous MK-2060 in Participants With Chronic and/or End-Stage Kidney DiseaseStatus: Recruiting, Estimated PCD: 2024-07-05
Clinical trial
A Randomized Parallel-group, Placebo-controlled, Double-blind, Event-driven, Multi-center Phase 2 Clinical Outcome Trial of Prevention of Arteriovenous Graft Thrombosis and Safety of MK-2060 in Patients With End Stage Renal Disease Receiving HemodialysisStatus: Active (not recruiting), Estimated PCD: 2024-07-10
Clinical trial
A Study to Evaluate Safety and Tolerability of Co-administration of MK-2060 and Clopidogrel in Participants With End-Stage Renal Disease on HemodialysisStatus: Completed, Estimated PCD: 2023-02-14
Clinical trial
Single and Multiple Dose Clinical Trial to Study the Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on HemodialysisStatus: Completed, Estimated PCD: 2021-12-20